Polymorphic antiviral nucleoside compounds

Details Polymorphic antiviral nucleoside compounds Polymorphic antiviral nucleoside compounds

2008-07-01

2008-07-01

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S043000, C514S885000, C424S085400

Reexamination Certificate

active

07393839

ABSTRACT:
The present invention relates to the polymorphic crystalline hydrochloride salts of a nucleoside valinate ester according to formula Ib, methods of treating diseases mediated by Hepatitis C Virus and pharmaceutical composition containing Ib

REFERENCES:
patent: 6277830 (2001-08-01), Ganguly et al.
patent: 6495677 (2002-12-01), Ramasamy et al.
patent: 2004/0121969 (2004-06-01), Hendricks et al.
patent: WO 01/45509 (2001-06-01), None
patent: WO 01/68034 (2001-09-01), None
patent: WO 2004/052905 (2004-06-01), None

Affiliated with

Also associated with

Rating

Polymorphic antiviral nucleoside compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorphic antiviral nucleoside compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic antiviral nucleoside compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2768824